Our founding partner Carl Li has been appointed as a board member of CF PharmTech., Inc.
Recently, our founding partner Mr. Carl Li has been appointed as a board member of CF PharmTech., Inc., which is preparing for domestic listings.
CF PharmTech., Inc. is a joint venture set up by Dr. Wenqing Liang and Dr. Li Li, who are scientists return from USA and have rich experience in pharmaceuticalresearchanddevelopment. CF PharmTech., Inc. also attracts many domestic talents in the field of pharmaceutical industries. CF PharmTech., Inc. focuses on the development and manufacturing of the drugs for the treatments of asthma, COPD, allergic rhinitis, etc., that have great demand in the clinical. CF PharmTech, Inc. has made many implementation of research projects regarding MDIs, FFNs, aerosol inhalation and dry powder inhaler (DPI), etc., which fill up much domestic blanks.
Mr. Carl Li will use professional legal knowledge to make independent judgments regarding to the strategy, operation, and management of the company and minimize the legal risks during its operation.